Understanding Drug Resistance in Cancer
One of the most frightening outcomes for a cancer patient is treatment failure. It often makes little sense to the patient and their medical team and leaves everyone uncertain about what is to come. One of the main reasons a cancer treatment may fail is because of drug-resistant cancer cells. Drug…...
Leukemia Drug Finds New Use
Approved by the FDA in 1993, the drug cladribine offered hope for the then-fatal blood cancer called hairy cell leukemia, or HCL, and was soon expanded as a therapy for multiple sclerosis. Developed by NFCR scientist Dr. Dennis Carson at the University of California, San Diego, cladribine acts like a…...
Strategic Media Partner
